Join date: May 23, 2022

0 Like Received
0 Comment Received
0 Best Answer

Rising research and development activities to cure or alleviate diseases such as cancer and other immunodeficiency ailments are driving the market for recombinant DNA technology. The success rate of genetically engineered human insulin in the treatment of diabetes has spurred the development of several other drugs, which is also fueling the Recombinant DNA Technology Market growth.

Also read : Diabetic Ulcer Treatment Market, Foliar Spray Market


Alina jonas

More actions